

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 9.47822826 |
| 2 | valine metabolic process (GO:0006573) | 7.12982209 |
| 3 | * brown fat cell differentiation (GO:0050873) | 7.11607903 |
| 4 | * triglyceride catabolic process (GO:0019433) | 6.99683548 |
| 5 | regulation of cholesterol storage (GO:0010885) | 6.83287396 |
| 6 | diacylglycerol metabolic process (GO:0046339) | 6.56398128 |
| 7 | positive regulation of fatty acid oxidation (GO:0046321) | 6.40426525 |
| 8 | * white fat cell differentiation (GO:0050872) | 6.21320089 |
| 9 | * acylglycerol catabolic process (GO:0046464) | 6.21319356 |
| 10 | * neutral lipid catabolic process (GO:0046461) | 6.21319356 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 5.93034275 |
| 12 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.89575301 |
| 13 | biotin metabolic process (GO:0006768) | 5.80211329 |
| 14 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.73409184 |
| 15 | lipid particle organization (GO:0034389) | 5.60582228 |
| 16 | lipid storage (GO:0019915) | 5.44784582 |
| 17 | fatty acid beta-oxidation (GO:0006635) | 5.42512753 |
| 18 | regulation of fatty acid oxidation (GO:0046320) | 5.22688043 |
| 19 | carnitine shuttle (GO:0006853) | 5.16901500 |
| 20 | triglyceride biosynthetic process (GO:0019432) | 5.13994817 |
| 21 | positive regulation of lipid storage (GO:0010884) | 5.05755183 |
| 22 | branched-chain amino acid catabolic process (GO:0009083) | 4.90848500 |
| 23 | acylglycerol biosynthetic process (GO:0046463) | 4.90586461 |
| 24 | neutral lipid biosynthetic process (GO:0046460) | 4.90586461 |
| 25 | branched-chain amino acid metabolic process (GO:0009081) | 4.90405957 |
| 26 | fatty acid oxidation (GO:0019395) | 4.79962239 |
| 27 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.73772773 |
| 28 | lipid oxidation (GO:0034440) | 4.70901005 |
| 29 | * glycerolipid catabolic process (GO:0046503) | 4.61954248 |
| 30 | polyol transport (GO:0015791) | 4.57858794 |
| 31 | fatty acid catabolic process (GO:0009062) | 4.55649292 |
| 32 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.53473330 |
| 33 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.53470918 |
| 34 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.43246141 |
| 35 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.33879722 |
| 36 | tricarboxylic acid cycle (GO:0006099) | 4.29913927 |
| 37 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.29825841 |
| 38 | response to phenylpropanoid (GO:0080184) | 4.27827502 |
| 39 | response to dietary excess (GO:0002021) | 4.26016890 |
| 40 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.23600133 |
| 41 | NADH metabolic process (GO:0006734) | 4.15990684 |
| 42 | negative regulation of lipid storage (GO:0010888) | 4.15541339 |
| 43 | negative regulation of protein autophosphorylation (GO:0031953) | 4.12015837 |
| 44 | carnitine transmembrane transport (GO:1902603) | 4.08424302 |
| 45 | protein heterotrimerization (GO:0070208) | 4.06589011 |
| 46 | ethanol oxidation (GO:0006069) | 4.06187448 |
| 47 | ovulation from ovarian follicle (GO:0001542) | 4.05701939 |
| 48 | regulation of lipid storage (GO:0010883) | 4.05663307 |
| 49 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.03739500 |
| 50 | thioester metabolic process (GO:0035383) | 3.98295459 |
| 51 | acyl-CoA metabolic process (GO:0006637) | 3.98295459 |
| 52 | thioester biosynthetic process (GO:0035384) | 3.97675756 |
| 53 | acyl-CoA biosynthetic process (GO:0071616) | 3.97675756 |
| 54 | positive regulation of lipid catabolic process (GO:0050996) | 3.93078100 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.92142455 |
| 56 | retinol metabolic process (GO:0042572) | 3.91327879 |
| 57 | phospholipid homeostasis (GO:0055091) | 3.88592383 |
| 58 | tricarboxylic acid metabolic process (GO:0072350) | 3.86801984 |
| 59 | coenzyme A biosynthetic process (GO:0015937) | 3.86437332 |
| 60 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.84418147 |
| 61 | * triglyceride metabolic process (GO:0006641) | 3.83602370 |
| 62 | primary alcohol metabolic process (GO:0034308) | 3.82318826 |
| 63 | alpha-linolenic acid metabolic process (GO:0036109) | 3.75669515 |
| 64 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.75647283 |
| 65 | carnitine transport (GO:0015879) | 3.74476722 |
| 66 | amino-acid betaine transport (GO:0015838) | 3.74476722 |
| 67 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.72484283 |
| 68 | cGMP-mediated signaling (GO:0019934) | 3.72229723 |
| 69 | negative regulation of metanephros development (GO:0072217) | 3.72163782 |
| 70 | negative regulation of granulocyte differentiation (GO:0030853) | 3.70384890 |
| 71 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.70364001 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.69530255 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.65328981 |
| 74 | response to epinephrine (GO:0071871) | 3.62703258 |
| 75 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.62689184 |
| 76 | fatty acid homeostasis (GO:0055089) | 3.62190917 |
| 77 | phosphatidic acid biosynthetic process (GO:0006654) | 3.61196426 |
| 78 | phosphatidic acid metabolic process (GO:0046473) | 3.61196426 |
| 79 | * acylglycerol metabolic process (GO:0006639) | 3.60340190 |
| 80 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.57142229 |
| 81 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.56654758 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56155869 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56155869 |
| 84 | positive regulation of glycolytic process (GO:0045821) | 3.56059812 |
| 85 | * neutral lipid metabolic process (GO:0006638) | 3.54831709 |
| 86 | alditol metabolic process (GO:0019400) | 3.53290860 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 3.53011770 |
| 88 | positive regulation of glucose import (GO:0046326) | 3.50379890 |
| 89 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.48963529 |
| 90 | negative regulation of lipid catabolic process (GO:0050995) | 3.48561475 |
| 91 | succinate metabolic process (GO:0006105) | 3.47392520 |
| 92 | protein localization to cell surface (GO:0034394) | 3.46459517 |
| 93 | L-serine transport (GO:0015825) | 3.43411366 |
| 94 | cellular response to epinephrine stimulus (GO:0071872) | 3.43048114 |
| 95 | positive regulation of glomerulus development (GO:0090193) | 3.42717056 |
| 96 | regulation of triglyceride catabolic process (GO:0010896) | 3.41724239 |
| 97 | complement activation, alternative pathway (GO:0006957) | 3.41667348 |
| 98 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.41122471 |
| 99 | intracellular lipid transport (GO:0032365) | 3.40930189 |
| 100 | NADPH regeneration (GO:0006740) | 3.40082853 |
| 101 | monocarboxylic acid catabolic process (GO:0072329) | 3.39652332 |
| 102 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.38612054 |
| 103 | regulation of cofactor metabolic process (GO:0051193) | 3.37856887 |
| 104 | regulation of coenzyme metabolic process (GO:0051196) | 3.37856887 |
| 105 | glycerol metabolic process (GO:0006071) | 3.36925889 |
| 106 | response to hydroperoxide (GO:0033194) | 3.36656387 |
| 107 | pentose-phosphate shunt (GO:0006098) | 3.36408869 |
| 108 | linoleic acid metabolic process (GO:0043651) | 3.36386145 |
| 109 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.35875574 |
| 110 | negative regulation of phagocytosis (GO:0050765) | 3.35626056 |
| 111 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.35289850 |
| 112 | transcytosis (GO:0045056) | 3.32967821 |
| 113 | positive regulation of cholesterol efflux (GO:0010875) | 3.30512929 |
| 114 | positive regulation of cholesterol transport (GO:0032376) | 3.29960336 |
| 115 | positive regulation of sterol transport (GO:0032373) | 3.29960336 |
| 116 | long-chain fatty acid transport (GO:0015909) | 3.28772283 |
| 117 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.23597941 |
| 118 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.23095640 |
| 119 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.21182323 |
| 120 | negative regulation of macrophage differentiation (GO:0045650) | 3.20407387 |
| 121 | positive regulation of macrophage cytokine production (GO:0060907) | 3.20215591 |
| 122 | acylglycerol homeostasis (GO:0055090) | 3.19617062 |
| 123 | triglyceride homeostasis (GO:0070328) | 3.19617062 |
| 124 | apoptotic cell clearance (GO:0043277) | 3.17437825 |
| 125 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.17116053 |
| 126 | 2-oxoglutarate metabolic process (GO:0006103) | 3.16794487 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 3.15895512 |
| 128 | endocrine hormone secretion (GO:0060986) | 3.13187830 |
| 129 | regulation of fatty acid metabolic process (GO:0019217) | 3.12603506 |
| 130 | regulation of cholesterol efflux (GO:0010874) | 3.12548924 |
| 131 | negative regulation of gluconeogenesis (GO:0045721) | 3.10544306 |
| 132 | regulation of sequestering of triglyceride (GO:0010889) | 10.4424328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.99395533 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.56412153 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.05832281 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66693777 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.63914271 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55811633 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48052794 |
| 8 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.47730909 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.45859362 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31399100 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15444871 |
| 12 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.08854211 |
| 13 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 14.8219887 |
| 14 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.88362211 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87621485 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86733028 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86354175 |
| 18 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.73587139 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.72716094 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69882316 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.69093221 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54281813 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49021601 |
| 24 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.48310176 |
| 25 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.48310176 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45930146 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42459791 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42413955 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41348873 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40743439 |
| 31 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.39466294 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38735912 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37906316 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32777636 |
| 35 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30760049 |
| 36 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26717376 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25881441 |
| 38 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23726633 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18187219 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17682424 |
| 41 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17243255 |
| 42 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14962834 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11967985 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10926560 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10110459 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07419796 |
| 47 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.06588919 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04023841 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03881353 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03881353 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02793740 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97813623 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97430795 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96508038 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96508038 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96207442 |
| 57 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95495394 |
| 58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95344948 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94074344 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.93440710 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93383119 |
| 62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93202951 |
| 63 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90995675 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90245088 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89815848 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89329651 |
| 67 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86897282 |
| 68 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86580635 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86092577 |
| 70 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.84320699 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84156299 |
| 72 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83251760 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83150753 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82235010 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82115045 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.81922843 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81481700 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81318496 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81315457 |
| 80 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81225548 |
| 81 | CBP_21632823_ChIP-Seq_H3396_Human | 0.80928875 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80882053 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79249777 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78458747 |
| 85 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77522426 |
| 86 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76995900 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76311832 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75460826 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75259365 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74912972 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.74516245 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73237715 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72738716 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72653067 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72593182 |
| 96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70585162 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70348874 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70248759 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.70175618 |
| 100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69118405 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.69035844 |
| 102 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.68418797 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.68007383 |
| 104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.67888834 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 0.67739493 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.67642652 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67009251 |
| 108 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.66828898 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66402033 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.65770385 |
| 111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.65484422 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.65369956 |
| 113 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.64386666 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64131846 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.63671596 |
| 116 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.63237350 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62703574 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.62513766 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.62005869 |
| 120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.61704225 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61182107 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60140945 |
| 123 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59824712 |
| 124 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59722586 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.59658297 |
| 126 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.59494196 |
| 127 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.59119483 |
| 128 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.58617300 |
| 129 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.57811031 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.57139314 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.56367997 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.56367997 |
| 133 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.55916217 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55529998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.02833420 |
| 2 | * MP0005666_abnormal_adipose_tissue | 4.85918971 |
| 3 | * MP0004130_abnormal_muscle_cell | 4.82055855 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.85146985 |
| 5 | * MP0005375_adipose_tissue_phenotype | 3.80389507 |
| 6 | * MP0004185_abnormal_adipocyte_glucose | 3.59153990 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.53975319 |
| 8 | MP0002971_abnormal_brown_adipose | 3.31291397 |
| 9 | MP0000003_abnormal_adipose_tissue | 3.22481393 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.12853523 |
| 11 | MP0003011_delayed_dark_adaptation | 2.74265002 |
| 12 | MP0009115_abnormal_fat_cell | 2.61164921 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.55950177 |
| 14 | MP0005275_abnormal_skin_tensile | 2.48285445 |
| 15 | MP0003724_increased_susceptibility_to | 2.39063868 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.35933404 |
| 17 | MP0005334_abnormal_fat_pad | 2.31250740 |
| 18 | MP0003646_muscle_fatigue | 2.29630318 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.21457702 |
| 20 | MP0005535_abnormal_body_temperature | 2.00889767 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.98280422 |
| 22 | MP0005503_abnormal_tendon_morphology | 1.93266896 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.92824830 |
| 24 | MP0004272_abnormal_basement_membrane | 1.91676413 |
| 25 | MP0003828_pulmonary_edema | 1.90484202 |
| 26 | * MP0002970_abnormal_white_adipose | 1.88882445 |
| 27 | MP0001661_extended_life_span | 1.87824177 |
| 28 | * MP0002118_abnormal_lipid_homeostasis | 1.79970361 |
| 29 | MP0006138_congestive_heart_failure | 1.62396501 |
| 30 | MP0003186_abnormal_redox_activity | 1.61355209 |
| 31 | MP0003868_abnormal_feces_composition | 1.60226230 |
| 32 | MP0003959_abnormal_lean_body | 1.58092325 |
| 33 | MP0000343_altered_response_to | 1.51031789 |
| 34 | MP0005448_abnormal_energy_balance | 1.46254864 |
| 35 | MP0003690_abnormal_glial_cell | 1.39228082 |
| 36 | MP0001881_abnormal_mammary_gland | 1.39124102 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.35539087 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.31615322 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.31195382 |
| 40 | MP0001544_abnormal_cardiovascular_syste | 1.29584920 |
| 41 | MP0005385_cardiovascular_system_phenoty | 1.29584920 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.29130673 |
| 43 | MP0000751_myopathy | 1.26204931 |
| 44 | MP0005330_cardiomyopathy | 1.25689762 |
| 45 | MP0002254_reproductive_system_inflammat | 1.25241724 |
| 46 | MP0005620_abnormal_muscle_contractility | 1.25030513 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.21055779 |
| 48 | MP0004087_abnormal_muscle_fiber | 1.20532411 |
| 49 | * MP0005452_abnormal_adipose_tissue | 1.20219885 |
| 50 | * MP0002078_abnormal_glucose_homeostasis | 1.19608342 |
| 51 | * MP0000609_abnormal_liver_physiology | 1.16605252 |
| 52 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16379733 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.14825644 |
| 54 | MP0005647_abnormal_sex_gland | 1.13640343 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.11521838 |
| 56 | MP0009840_abnormal_foam_cell | 1.08707253 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.08670438 |
| 58 | MP0002972_abnormal_cardiac_muscle | 1.08136140 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.05413445 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.04781370 |
| 61 | MP0003045_fibrosis | 1.02512668 |
| 62 | MP0002796_impaired_skin_barrier | 1.01061456 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.00253394 |
| 64 | MP0004147_increased_porphyrin_level | 0.99181264 |
| 65 | MP0005365_abnormal_bile_salt | 0.99018872 |
| 66 | MP0002909_abnormal_adrenal_gland | 0.98308203 |
| 67 | MP0002060_abnormal_skin_morphology | 0.93985759 |
| 68 | MP0005164_abnormal_response_to | 0.93613697 |
| 69 | MP0004084_abnormal_cardiac_muscle | 0.92928834 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.91144399 |
| 71 | MP0004036_abnormal_muscle_relaxation | 0.89831242 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.89403390 |
| 73 | MP0002933_joint_inflammation | 0.88473106 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 0.86164993 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83538845 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.83242721 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.82475772 |
| 78 | MP0010630_abnormal_cardiac_muscle | 0.82067889 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.79681553 |
| 80 | MP0003948_abnormal_gas_homeostasis | 0.75817961 |
| 81 | MP0000604_amyloidosis | 0.74725149 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.74549524 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.72444804 |
| 84 | MP0001756_abnormal_urination | 0.72006033 |
| 85 | MP0002168_other_aberrant_phenotype | 0.70864059 |
| 86 | MP0000858_altered_metastatic_potential | 0.70621633 |
| 87 | MP0000249_abnormal_blood_vessel | 0.69240536 |
| 88 | MP0005332_abnormal_amino_acid | 0.69219461 |
| 89 | MP0000749_muscle_degeneration | 0.68278561 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.67009010 |
| 91 | MP0009643_abnormal_urine_homeostasis | 0.66573308 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.65869946 |
| 93 | MP0004484_altered_response_of | 0.65520657 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.64717841 |
| 95 | MP0002006_tumorigenesis | 0.64056526 |
| 96 | MP0003279_aneurysm | 0.62320502 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.62004882 |
| 98 | MP0005360_urolithiasis | 0.60938035 |
| 99 | MP0009763_increased_sensitivity_to | 0.60391529 |
| 100 | MP0002106_abnormal_muscle_physiology | 0.58845052 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.58689952 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.58297489 |
| 103 | MP0005388_respiratory_system_phenotype | 0.58088379 |
| 104 | MP0002133_abnormal_respiratory_system | 0.58088379 |
| 105 | MP0003075_altered_response_to | 0.57418698 |
| 106 | * MP0003953_abnormal_hormone_level | 0.57063535 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.56661786 |
| 108 | MP0001958_emphysema | 0.56509174 |
| 109 | MP0005165_increased_susceptibility_to | 0.56358771 |
| 110 | MP0004883_abnormal_blood_vessel | 0.56161868 |
| 111 | MP0002139_abnormal_hepatobiliary_system | 0.55864390 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.54845232 |
| 113 | MP0003329_amyloid_beta_deposits | 0.53960435 |
| 114 | MP0001764_abnormal_homeostasis | 0.52080915 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.51350382 |
| 116 | MP0001177_atelectasis | 0.49914650 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.49216925 |
| 118 | MP0003448_altered_tumor_morphology | 0.48587957 |
| 119 | MP0005508_abnormal_skeleton_morphology | 0.47627078 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.47188314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 7.49678830 |
| 2 | Acanthosis nigricans (HP:0000956) | 6.27063893 |
| 3 | Hypertriglyceridemia (HP:0002155) | 5.56382042 |
| 4 | Hyperglycinuria (HP:0003108) | 5.16915495 |
| 5 | Myoglobinuria (HP:0002913) | 4.47322649 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.46202927 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33816677 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 4.33816677 |
| 9 | Nausea (HP:0002018) | 4.25981085 |
| 10 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.24041665 |
| 11 | Difficulty running (HP:0009046) | 4.07709901 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.07580354 |
| 13 | Protrusio acetabuli (HP:0003179) | 4.02126974 |
| 14 | Complement deficiency (HP:0004431) | 3.88505786 |
| 15 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.82040567 |
| 16 | Epidermoid cyst (HP:0200040) | 3.69721320 |
| 17 | Increased connective tissue (HP:0009025) | 3.67550034 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.57864339 |
| 19 | Hydroxyprolinuria (HP:0003080) | 3.54868091 |
| 20 | Abnormality of proline metabolism (HP:0010907) | 3.54868091 |
| 21 | Back pain (HP:0003418) | 3.46857632 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 3.42564943 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.42564943 |
| 24 | Bone cyst (HP:0012062) | 3.39215637 |
| 25 | Ketoacidosis (HP:0001993) | 3.36080820 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.35211734 |
| 27 | Axonal loss (HP:0003447) | 3.34560025 |
| 28 | Pigmentary retinal degeneration (HP:0001146) | 3.30016109 |
| 29 | Myocardial infarction (HP:0001658) | 3.27882308 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.25149302 |
| 31 | Vertebral compression fractures (HP:0002953) | 3.24403150 |
| 32 | Multiple enchondromatosis (HP:0005701) | 3.24086750 |
| 33 | Increased muscle lipid content (HP:0009058) | 3.23327954 |
| 34 | Facial shape deformation (HP:0011334) | 3.22170961 |
| 35 | Potter facies (HP:0002009) | 3.22170961 |
| 36 | Insulin resistance (HP:0000855) | 3.17479286 |
| 37 | Ketosis (HP:0001946) | 3.11875624 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.06835036 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.99050831 |
| 40 | Long foot (HP:0001833) | 2.92228890 |
| 41 | Muscle fiber splitting (HP:0003555) | 2.88806559 |
| 42 | Growth hormone excess (HP:0000845) | 2.87691944 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.85503318 |
| 44 | Large hands (HP:0001176) | 2.83835956 |
| 45 | Skin nodule (HP:0200036) | 2.82442063 |
| 46 | Lipoatrophy (HP:0100578) | 2.81937297 |
| 47 | Broad metatarsal (HP:0001783) | 2.81428329 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.78407938 |
| 49 | Hepatic necrosis (HP:0002605) | 2.74843508 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74372792 |
| 51 | Abnormality of complement system (HP:0005339) | 2.73442033 |
| 52 | Xanthomatosis (HP:0000991) | 2.70054332 |
| 53 | Hyperammonemia (HP:0001987) | 2.69913367 |
| 54 | Pulmonary artery stenosis (HP:0004415) | 2.69522128 |
| 55 | Subcapsular cataract (HP:0000523) | 2.64627968 |
| 56 | Hyporeflexia of lower limbs (HP:0002600) | 2.63921364 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.60929698 |
| 58 | Toxemia of pregnancy (HP:0100603) | 2.60116450 |
| 59 | Ankle contracture (HP:0006466) | 2.59659666 |
| 60 | Frequent falls (HP:0002359) | 2.58511836 |
| 61 | Hyperglycinemia (HP:0002154) | 2.58414484 |
| 62 | Abnormal eating behavior (HP:0100738) | 2.56474397 |
| 63 | Spinal rigidity (HP:0003306) | 2.56321794 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.55904793 |
| 65 | Polycythemia (HP:0001901) | 2.53577873 |
| 66 | Right ventricular cardiomyopathy (HP:0011663) | 2.53237528 |
| 67 | Facial diplegia (HP:0001349) | 2.52099104 |
| 68 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.50627644 |
| 69 | Abnormality of alanine metabolism (HP:0010916) | 2.50627644 |
| 70 | Hyperalaninemia (HP:0003348) | 2.50627644 |
| 71 | Conjunctival hamartoma (HP:0100780) | 2.47628556 |
| 72 | Pancreatitis (HP:0001733) | 2.43142139 |
| 73 | Polyphagia (HP:0002591) | 2.42969470 |
| 74 | Hypercortisolism (HP:0001578) | 2.39225432 |
| 75 | Ectopia lentis (HP:0001083) | 2.35746094 |
| 76 | Abnormality of the periventricular white matter (HP:0002518) | 2.35420772 |
| 77 | Decreased subcutaneous fat (HP:0001002) | 2.35408319 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.34858826 |
| 79 | Hypercholesterolemia (HP:0003124) | 2.32869231 |
| 80 | Hepatosplenomegaly (HP:0001433) | 2.31398587 |
| 81 | Abnormal hemoglobin (HP:0011902) | 2.30658573 |
| 82 | Ileus (HP:0002595) | 2.30594804 |
| 83 | Abnormal cartilage morphology (HP:0002763) | 2.29230027 |
| 84 | Tetraparesis (HP:0002273) | 2.28869118 |
| 85 | Polar cataract (HP:0010696) | 2.27776287 |
| 86 | Hyperglycemia (HP:0003074) | 2.27662323 |
| 87 | Palpitations (HP:0001962) | 2.27311725 |
| 88 | Muscle stiffness (HP:0003552) | 2.27261092 |
| 89 | Prenatal maternal abnormality (HP:0002686) | 2.26350387 |
| 90 | Colitis (HP:0002583) | 2.25260403 |
| 91 | Polygenic inheritance (HP:0010982) | 2.19793102 |
| 92 | Exercise-induced myalgia (HP:0003738) | 2.17769253 |
| 93 | Cerebral edema (HP:0002181) | 2.16889178 |
| 94 | Neck muscle weakness (HP:0000467) | 2.15658285 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 2.13985936 |
| 96 | Vascular tortuosity (HP:0004948) | 2.11404476 |
| 97 | Renal cortical cysts (HP:0000803) | 2.10798563 |
| 98 | Follicular hyperkeratosis (HP:0007502) | 2.10748187 |
| 99 | Increased serum pyruvate (HP:0003542) | 2.09346402 |
| 100 | Abnormality of glycolysis (HP:0004366) | 2.09346402 |
| 101 | Hyperpituitarism (HP:0010514) | 2.06902008 |
| 102 | Acute encephalopathy (HP:0006846) | 2.05230791 |
| 103 | Cerebral inclusion bodies (HP:0100314) | 2.05143608 |
| 104 | Infantile muscular hypotonia (HP:0008947) | 2.04679486 |
| 105 | Amyloidosis (HP:0011034) | 2.01779822 |
| 106 | Beaking of vertebral bodies (HP:0004568) | 2.00154262 |
| 107 | Lymphangioma (HP:0100764) | 1.99918692 |
| 108 | Accelerated skeletal maturation (HP:0005616) | 1.99687722 |
| 109 | Esophageal varix (HP:0002040) | 1.99651066 |
| 110 | Prominent supraorbital ridges (HP:0000336) | 1.96037805 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95268547 |
| 112 | Myotonia (HP:0002486) | 1.94654007 |
| 113 | Mesangial abnormality (HP:0001966) | 1.94403652 |
| 114 | Hyperthyroidism (HP:0000836) | 1.92354926 |
| 115 | Premature rupture of membranes (HP:0001788) | 1.91474615 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.90355339 |
| 117 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.89430666 |
| 118 | Gowers sign (HP:0003391) | 1.88364129 |
| 119 | Tubulointerstitial fibrosis (HP:0005576) | 1.87849033 |
| 120 | Vomiting (HP:0002013) | 1.87248779 |
| 121 | Aortic dissection (HP:0002647) | 1.86332688 |
| 122 | Venous abnormality (HP:0002624) | 1.85091925 |
| 123 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84723757 |
| 124 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84723757 |
| 125 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84723757 |
| 126 | Striae distensae (HP:0001065) | 1.84152357 |
| 127 | Abnormality of serum amino acid levels (HP:0003112) | 1.83507582 |
| 128 | Proximal tubulopathy (HP:0000114) | 1.83405152 |
| 129 | Hamartoma of the eye (HP:0010568) | 1.83016678 |
| 130 | Neoplasm of the adrenal gland (HP:0100631) | 1.79828956 |
| 131 | Mutism (HP:0002300) | 1.77976104 |
| 132 | Neonatal death (HP:0003811) | 1.77940183 |
| 133 | Opisthotonus (HP:0002179) | 1.77486364 |
| 134 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77025893 |
| 135 | Abnormality of purine metabolism (HP:0004352) | 1.76952625 |
| 136 | Lethargy (HP:0001254) | 1.76951499 |
| 137 | Atrioventricular block (HP:0001678) | 1.76809269 |
| 138 | Scapular winging (HP:0003691) | 1.76785678 |
| 139 | Aortic aneurysm (HP:0004942) | 1.75946577 |
| 140 | Acute necrotizing encephalopathy (HP:0006965) | 1.75455270 |
| 141 | Dilated cardiomyopathy (HP:0001644) | 1.75097429 |
| 142 | Increased mean platelet volume (HP:0011877) | 1.72695706 |
| 143 | Abnormal glucose tolerance (HP:0001952) | 1.66447755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 5.19053744 |
| 2 | TRIB3 | 5.15476582 |
| 3 | BCKDK | 4.34686378 |
| 4 | SIK1 | 3.73548410 |
| 5 | CAMK1G | 3.68072476 |
| 6 | PDK3 | 3.24265599 |
| 7 | PDK4 | 3.24265599 |
| 8 | RIPK1 | 2.64997511 |
| 9 | ERN1 | 2.41892220 |
| 10 | TIE1 | 2.38721354 |
| 11 | LMTK2 | 2.28216399 |
| 12 | PDK2 | 2.22385417 |
| 13 | TESK1 | 2.04437368 |
| 14 | CDK9 | 2.01888085 |
| 15 | EPHB2 | 1.92106567 |
| 16 | MST1R | 1.86094000 |
| 17 | PRKAA2 | 1.82791727 |
| 18 | MAPK4 | 1.69098470 |
| 19 | INSRR | 1.61263743 |
| 20 | TGFBR2 | 1.60927592 |
| 21 | TTN | 1.58287761 |
| 22 | FGFR3 | 1.56769751 |
| 23 | PKN2 | 1.40402937 |
| 24 | PDGFRA | 1.33371986 |
| 25 | NLK | 1.32662678 |
| 26 | PRKD3 | 1.30065489 |
| 27 | MAP2K1 | 1.25336523 |
| 28 | FGFR2 | 1.24299984 |
| 29 | PIK3CA | 1.21074576 |
| 30 | MYLK | 1.20618859 |
| 31 | KDR | 1.13938745 |
| 32 | FRK | 1.13100094 |
| 33 | JAK1 | 1.12798494 |
| 34 | FGFR4 | 1.12680520 |
| 35 | LATS1 | 1.12591424 |
| 36 | CDC42BPA | 1.11341187 |
| 37 | PHKG2 | 1.09997872 |
| 38 | PHKG1 | 1.09997872 |
| 39 | GRK5 | 1.08918290 |
| 40 | NME2 | 1.00293950 |
| 41 | TEC | 0.98036595 |
| 42 | RIPK4 | 0.93332485 |
| 43 | NEK9 | 0.92790208 |
| 44 | CDK6 | 0.92512160 |
| 45 | PDPK1 | 0.90891881 |
| 46 | MAP3K13 | 0.89704394 |
| 47 | ADRBK1 | 0.88344823 |
| 48 | PRKAA1 | 0.85405059 |
| 49 | KIT | 0.85013820 |
| 50 | MET | 0.84682414 |
| 51 | EEF2K | 0.84573289 |
| 52 | FER | 0.84186671 |
| 53 | JAK2 | 0.81451230 |
| 54 | KSR2 | 0.80598973 |
| 55 | PRKCH | 0.80120360 |
| 56 | PTK2 | 0.73269256 |
| 57 | PRPF4B | 0.71369155 |
| 58 | ZAP70 | 0.71201640 |
| 59 | PDK1 | 0.70909000 |
| 60 | PRKD1 | 0.69414196 |
| 61 | PTK2B | 0.69168487 |
| 62 | DAPK2 | 0.67758629 |
| 63 | PRKG1 | 0.67312684 |
| 64 | LATS2 | 0.62886696 |
| 65 | ILK | 0.62757104 |
| 66 | JAK3 | 0.62558338 |
| 67 | DDR2 | 0.62120108 |
| 68 | MTOR | 0.61028983 |
| 69 | PINK1 | 0.60704322 |
| 70 | IRAK3 | 0.60007820 |
| 71 | MAPK3 | 0.59762819 |
| 72 | MAP3K6 | 0.59158360 |
| 73 | EPHB1 | 0.59141715 |
| 74 | MAP2K4 | 0.59121017 |
| 75 | OBSCN | 0.58526387 |
| 76 | IRAK1 | 0.57908064 |
| 77 | RET | 0.56958689 |
| 78 | PRKACG | 0.56647885 |
| 79 | PDGFRB | 0.56273261 |
| 80 | GSK3A | 0.54678763 |
| 81 | PRKACB | 0.52688067 |
| 82 | PAK4 | 0.52535283 |
| 83 | CAMKK1 | 0.51127955 |
| 84 | CDK4 | 0.50737148 |
| 85 | MAP2K3 | 0.50717055 |
| 86 | CAMKK2 | 0.50060979 |
| 87 | STK38L | 0.49207347 |
| 88 | PKN1 | 0.48822080 |
| 89 | TGFBR1 | 0.48564038 |
| 90 | FLT3 | 0.47580307 |
| 91 | EPHA3 | 0.47515200 |
| 92 | ABL1 | 0.47507535 |
| 93 | MAPK7 | 0.47448552 |
| 94 | MAPK11 | 0.46857953 |
| 95 | PRKG2 | 0.45563413 |
| 96 | MAPKAPK3 | 0.45529918 |
| 97 | MAPK12 | 0.45290523 |
| 98 | EIF2AK2 | 0.45288670 |
| 99 | FES | 0.45222766 |
| 100 | STK38 | 0.44740753 |
| 101 | STK3 | 0.44093648 |
| 102 | ARAF | 0.43148479 |
| 103 | ABL2 | 0.42218356 |
| 104 | PTK6 | 0.41987602 |
| 105 | SGK2 | 0.41820795 |
| 106 | RPS6KA3 | 0.41297568 |
| 107 | PIM2 | 0.41199567 |
| 108 | PAK2 | 0.39449963 |
| 109 | AKT2 | 0.38870006 |
| 110 | BLK | 0.38856553 |
| 111 | MARK2 | 0.38117440 |
| 112 | BMX | 0.36825163 |
| 113 | FGFR1 | 0.36637567 |
| 114 | SGK3 | 0.36386591 |
| 115 | PRKD2 | 0.36155262 |
| 116 | DMPK | 0.35548425 |
| 117 | CSK | 0.35065219 |
| 118 | CAMK1 | 0.34233662 |
| 119 | * IGF1R | 0.33364773 |
| 120 | TYRO3 | 0.32163219 |
| 121 | TBK1 | 0.32001296 |
| 122 | CLK1 | 0.31574096 |
| 123 | SCYL2 | 0.31546378 |
| 124 | MOS | 0.31247349 |
| 125 | MAP3K1 | 0.30469845 |
| 126 | DAPK3 | 0.30355861 |
| 127 | SRC | 0.30243179 |
| 128 | MAP3K9 | 0.30009830 |
| 129 | MAP3K3 | 0.29453160 |
| 130 | * INSR | 0.28845381 |
| 131 | TRPM7 | 0.28422531 |
| 132 | TYK2 | 0.28168821 |
| 133 | RPS6KB1 | 0.25264975 |
| 134 | IRAK2 | 0.25159524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.92783390 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.66364624 |
| 3 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 4.27782094 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.97603907 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.81181089 |
| 6 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.55561948 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.44099592 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.15861582 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.94488632 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.66115799 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.30541078 |
| 12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.22127942 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.08927818 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03324226 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92358430 |
| 16 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.90648560 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88853065 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66170921 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.55660148 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54269775 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43134007 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41256563 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36381429 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31986999 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.31753279 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15565088 |
| 27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11855011 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11790888 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05037621 |
| 30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.02613118 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92896983 |
| 32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.91575277 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90433646 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89977939 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88257184 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86624710 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81734093 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77596638 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71100182 |
| 40 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68495659 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.68424362 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68063900 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67457231 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65753800 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63826499 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62614519 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61930793 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59625751 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55635185 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55541288 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55220449 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55046415 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54728734 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.52680884 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51154339 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48792578 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48748372 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45454776 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44855494 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43004682 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41990412 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41322317 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39620297 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39125902 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.37966923 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.37853991 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34579651 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34387258 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34259556 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33706957 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32895438 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32112373 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31941117 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30499867 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30409109 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29805280 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29321183 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29265343 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28645606 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27598041 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27571694 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26590937 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25740410 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25462454 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.25005930 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24793846 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24692964 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24412522 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.23143453 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22461486 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21817440 |
| 92 | Melanoma_Homo sapiens_hsa05218 | 0.21807027 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21540770 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21024318 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20406319 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20180358 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19770716 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18908960 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18084870 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18009969 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17858608 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17110140 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16833485 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16375023 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.15982730 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.15632797 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.14035086 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.12663152 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.11510187 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11331307 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10626000 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.10598931 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.08734117 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.08169217 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07656178 |
| 116 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.07644244 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.07529399 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.06825581 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.06736267 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.03175271 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.02664041 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.00356479 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0071346 |

